C-SRRNA
Live / Registered — Registered (as of 12 Dec 2023)
What this means for you
Registered since 12 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97151041
- Registration number
- 7243728
- Mark type
- Stylized text
- Filed
- 01 Dec 2021
- Published for opposition
- 09 May 2023
- Registered
- 12 Dec 2023
- Attorney of record
- Leonard D. Bowersox
Goods and services
- Class 005 — Pharmaceuticals: Dosage medium preparations, namely, pharmaceutical preparations for the treatment and prevention of infectious diseases, cancer, and aging-related diseases; vaccines; regenerative medicine, namely, pharmaceuticals for cell rejuvenation
Owner
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
Prosecution history
- 12 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 07 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Aug 2023 — USE AMENDMENT FILED
- 22 Aug 2023 — SOU EXTENSION 1 GRANTED
- 15 Aug 2023 — SOU EXTENSION 1 FILED
- 22 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Aug 2023 — TEAS STATEMENT OF USE RECEIVED
- 04 Jul 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 May 2023 — PUBLISHED FOR OPPOSITION